Acta Oncologica · 1988 · 257 citations · 19 references
MedicineOncologyRadiation OncologyRadiation DosimetryRadiobiologyTreatment PlanningExternal Beam RadiotherapyLaryngeal CancerRadiation Dose FractionationRadiation TherapyRadiobiological ConsiderationsDose ResponseLate ComplicationsRadiotherapy Dose EscalationRadiotherapy FractionationRepopulation EffectsTherapeutic Ratio ModelingTherapy SchedulingTotal Dose
Split‑course radiation was introduced in 1978 as an alternative to conventional daily irradiation. The schedule, based on Cohen’s models for squamous cell carcinoma and vascular damage, was expected to improve tumour control and reduce late complications, but was later abandoned after analysis of dose‑response data. Split‑course treatment did not improve tumour control, increased late complications.
AbstractBased on our experience with conventional, daily irradiation, a split-course radiation schedule was introduced in 1978. The schedule, which was based on Cohen's models for squamous cell carcinoma and vascular damage respectively, predicted an improved tumour control and a reduced rate of late complications, e.g. late oedema, if the conventional, daily treatment was replaced by a split-course schedule. The schedule has later been abandoned, but the experience gained from split-course treatment at various dose levels has been analysed and the results compared with those obtained by conventional radiation. The data allowed construction of dose-response curves and estimation of iso-effect doses. Split-course treatment was associated with a significantly reduced therapeutic ratio because, disappointingly, it did not improve tumour control, and the severity of late complications grew. No late complications were avoided by introducing a 3-week pause in the radiation therapy regimen, nor was the tumour response improved despite a 12-Gy increase in total dose. This indicates a significant repopulation corresponding to more than 0.5 Gy/day, equivalent to an up to 100-fold increase of the number of clonogenic tumour cells during the pause—an increase that occurred despite the decrease, clinically, of the tumours during this period.Key Words: Therapeutic radiologylaryngeal cancercomparison conventional vs split-coursetumour controloedemafistulas
19
B. Maciejewski, Gunhild Preuss-Bayer, Klaus-Rüdiger Trott · International Journal of Radiation Oncology*Biology*Physics · 1983 · 285 citations
Medicine, Oncology, Otolaryngology +14
Jens Overgaard, Hanne Sand Hansen, Karsten Jøsrgensen et al. · International Journal of Radiation Oncology*Biology*Physics · 1986 · 240 citations